Abbott LaboratoriesXSWX:ABT +0.66%80 PEG Ratio is 5.22 as of Jun. 28, 2026, which is 137% above its 10-year median of 2.20. GuruFocus rates XSWX:ABT with a GF Score™ of 80/100 and a GF Value™ of CHF104.56. Among 207 Medical Devices & Instruments companies, Abbott Laboratories ranks worse than 82.13% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Abbott Laboratories's PEG Ratio or its related term are showing as below:
XSWX:ABT'
s PEG Ratio Range Over the Past 10 Years
Min: 0.89 Med: 2.2 Max: 85.4
Current: 5.16
During the past 13 years, Abbott Laboratories's highest PEG Ratio was 85.40. The lowest was 0.89. And the median was 2.20.
XSWX:ABT's PEG Ratio is ranked worse than 82.13% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 2.03
vs XSWX:ABT: 5.16
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Abbott Laboratories (XSWX:ABT) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Abbott Laboratories PEG Ratio Related Terms
Abbott Laboratories PEG Ratio Historical Data
* Premium members only.
The historical data trend for Abbott Laboratories's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Abbott Laboratories's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Abbott Laboratories (XSWX:ABT) has a PEG Ratio of 5.22 as of Jun. 28, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Abbott Laboratories and its competitors. This is 137% above median its historical median of 2.20. Over the past decade, Abbott Laboratories' PEG Ratio has ranged from 0.89 to 85.40. According to the industry distribution chart, Abbott Laboratories ranks #170 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 82.1%.
Is Abbott Laboratories' PEG Ratio too high?
Abbott Laboratories' current PEG Ratio of 5.22 is 137% above median its 10-year median of 2.20. Over the past 10 years, this metric has ranged from a low of 0.89 to a high of 85.40. The Medical Devices & Instruments industry median PEG Ratio is 2.03. Abbott Laboratories' value of 5.22 is 157.1% above this industry median. Based on the distribution chart, Abbott Laboratories ranks #170 out of 207 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Abbott Laboratories has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' PEG Ratio compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #170 out of 207 companies for PEG Ratio. This places Abbott Laboratories in the lower half of its industry. The industry median PEG Ratio is 2.03. Abbott Laboratories' value of 5.22 is 157.1% above this benchmark. Historically, Abbott Laboratories' own PEG Ratio has ranged from 0.89 to 85.40 over the past decade. While the company's 10-year median is 2.20 vs. the industry median of 2.03, Abbott Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.03, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current PEG Ratio of 5.22 is 157.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current PEG Ratio is 5.22, which is 137% above median its own 10-year median of 2.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current PEG Ratio of 5.22. The stock's GF Value™ is CHF104.56, compared to a current price of CHF76.00 — trading 27.3% below its estimated fair value. The current PEG Ratio is 5.22, which is 137% above median its 10-year median of 2.20 and 157.1% above the Medical Devices & Instruments industry median of 2.03. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current PEG Ratio is 5.22 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of CHF76.00 is trading 27.3% below its estimated GF Value™ of CHF104.56.
Key valuation signals for XSWX:ABT:
PEG Ratio: 5.22 (137% above median its 10-year median of 2.20)
GF Value™: CHF104.56 vs. price of CHF76.00 (27.3% below fair value)
Industry Position: 157.1% above the Medical Devices & Instruments median (#170 of 207)
No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score
Get the complete analysis for XSWX:ABT
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ABT has been successfully added to your 
